Fyodor Biotechnologies
500 Global1 known investors
Find your way into Fyodor Biotechnologies
Fyodor Biosciences develops innovative diagnostics, medicines, and healthcare solutions with a focus on accessible global health. The company is led by scientists and health leaders with expertise in biomedical research and biotechnology.
Founders & leadership
DE
Dr. Eddy AgboFounder & CEO
Investors · 1
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2013 | $729.8K |
| National Science Foundation | Phase II | 2012 | $476.9K |
| National Science Foundation | Phase I | 2012 | $150K |
| National Science Foundation | Phase I | 2011 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Fyodor Biotechnologies do?
- Fyodor Biosciences develops innovative diagnostics, medicines, and healthcare solutions with a focus on accessible global health. The company is led by scientists and health leaders with expertise in biomedical research and biotechnology.
- Who founded Fyodor Biotechnologies?
- Fyodor Biotechnologies was founded by Dr. Eddy Agbo.
- Who are Fyodor Biotechnologies's investors?
- Fyodor Biotechnologies's investors include 500 Global.